Skip to main content

Advertisement

Log in

Formulation and evaluation of ethosomes for transdermal delivery of lamivudine

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the present research was to investigate the mechanism for improved intercellular and intracellular drug delivery from ethosomes using visualization techniques and cell line study. Ethosomal formulations were prepared using lamivudine as model drug and characterized in vitro, ex vivo and in vivo. Transmission electron microscopy, scanning electron microscopy, and fluorescence microscopy were employed to determine the effect of ethosome on ultrastructure of skin. Cytotoxicity and cellular uptake of ethosome were determined using T-lymphoid cell line (MT-2). The optimized ethosomal formulation showed 25 times higher transdermal flux (68.4±3.5 µg/cm2/h) across the rat skin as compared with that of lamivudine solution (2.8±0.2 µg/cm2/h). Microscopic studies revealed that ethosomes influenced the ultrastructure of stratum corneum. Distinct regions with lamellar stacks derived from vesicles were observed in intercellular region of deeper skin layers. Results of cellular uptake study showed significantly higher intracellular uptake of ethosomes (85.7%±4.5%) as compared with drug solution (24.9%±1.9%). The results of the characterization studies indicate that lipid perturbation along with elasticity of ethosomes vesicles seems to be the main contributor for improved skin permeation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jarvis B, Faulds D. Lamivudine: a review of its therapeutic potential in chronic hepatitis B.Drugs. 1999;58:101–141.

    Article  PubMed  CAS  Google Scholar 

  2. Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine-loaded mannosylated poly(propyleneimine) dendrimer.Biochim Biophys Acta. 2007;1770:681–686.

    PubMed  CAS  Google Scholar 

  3. Schreier H, Bouwstra J. Liposomes and niosomes as a drug carriers: dermal and transdermal drug delivery.J Control Release. 1994;30:1–15.

    Article  CAS  Google Scholar 

  4. Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A. The skin: a pathway for the systemic treatment with patches and lipid based agent carriers.Adv Drug Deliv Rev. 1996;18:349–378.

    Article  CAS  Google Scholar 

  5. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.J Control Release. 2000;65:403–418.

    Article  PubMed  CAS  Google Scholar 

  6. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 540 934. July 30, 1996.

  7. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 716 638. October 2, 1998.

  8. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier.Biomaterials. 2001;22:3053–3059.

    Article  PubMed  CAS  Google Scholar 

  9. Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent.Ind J Pharma Sci. 2004;66:72–81.

    CAS  Google Scholar 

  10. Bangham AD, Standish MM, Watkins JC. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations.J Mol Biol. 1965;13:253–259.

    Article  PubMed  CAS  Google Scholar 

  11. Lopez-Pinto JM, Gonzalez-Rodriguez ML, Robasco AM. Effect of cholesterol and ethanol on dermal delivery of DPPC liposome.Int J Pharm. 2005;298:1–12.

    Article  PubMed  CAS  Google Scholar 

  12. Jain S, Jain P, Jain NK. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation.Drug Dev Ind Pharm. 2003;29:1013–1026.

    Article  PubMed  CAS  Google Scholar 

  13. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation.Curr Drug Deliv. 2005;2:223–233.

    Article  PubMed  CAS  Google Scholar 

  14. Bedoya LM, Sanchez-Palomino S, Abad MJ, Bermejo P, Alcami J. Anti-HIV activity of medicinal plant extracts.J Ethnopharmacol. 2001;77:113–116.

    Article  PubMed  CAS  Google Scholar 

  15. Dusserre N, Lessard C, Paquette N, et al. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics.AIDS. 1995;9:833–841.

    Article  PubMed  CAS  Google Scholar 

  16. Uslu B, Ozkan SA. Determination of lamivudine and zidovudine in binary mixtures using first derivative spectrophotometric, first derivative of the ratio-spectra and high performance liquid chromatography-UV methods.Anal Chim Acta. 2002;466:175–185.

    Article  CAS  Google Scholar 

  17. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.J Control Release. 2005;106:99–110.

    Article  PubMed  CAS  Google Scholar 

  18. Lasic D, Weiner N, Riaz M, Martin F. Liposomes. In: Lieberman A, Rieger M, Banker G, eds.Pharmaceutical Dosage Forms: Disperse Systems. vol. 3. New York, NY: Marcel Dekker; 1998;43–86.

    Google Scholar 

  19. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes Vs liposomes.Biomaterials. 2000;21:1879–1885.

    Article  PubMed  CAS  Google Scholar 

  20. Van den Bergh BAI, Swartzendruber DC, Bos-Van der Geest A, et al. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy.J Microscopy. 1997;187:125–133.

    Article  Google Scholar 

  21. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism(s) of action.Int J Pharm. 1992;80:17–31.

    Article  CAS  Google Scholar 

  22. Krishnaiah YSR, Bhaskar P, Satyanarayana V. Penetration-enhancing effect of ethanol water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin.Pharm Dev Technol. 2004;9:63–74.

    Article  PubMed  CAS  Google Scholar 

  23. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membrane from an ethosomal carrier.J Control Release. 2004;187:1–15.

    Google Scholar 

  24. Oussoren C, Magnani M, Fraternale A, et al. Liposomes as carrier of the antiviral agent dideoxycytidine-5′-triphosphate.Int J Pharm. 1999;180:261–270.

    Article  PubMed  CAS  Google Scholar 

  25. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis.Annu Rev Biochem. 1983;52:223–261.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Subheet Jain.

Additional information

December 21, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, S., Tiwary, A.K., Sapra, B. et al. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8, 111 (2007). https://doi.org/10.1208/pt0804111

Download citation

  • Received:

  • Revised:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt0804111

Keywords

Navigation